Expression of gastrin-releasing peptide receptors in endometrial cancer

Journal of the American College of Surgeons

Volumn 196, Issue 6, 2003, Pages 898-904

  Levine, Lyuba ^a,b   Licci III, Joseph A ^a   Townsend Jr , Courtney M ^b   Hellmich, Mark R ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; BOMBESIN RELATED PEPTIDE; BOMBESIN RELATED PEPTIDE RECEPTOR; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

CALCIUM CELL LEVEL; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOMETRIUM CANCER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA ISOLATION;

EID: 0037647085     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(03)00290-4     Document Type: Review

References (36)

1. SEER Report: Statistical Report. NCI: www.nci.nih.gov.
2. Antunes CMF, Stolley PD, Rosenshein MB, et al. Endometrial cancer and estrogen use. N Engl J Med 1979;300:9-13.
3. Gusberg SB. Classics in oncology-precursors of corpus carcinoma estrogens and adenomatous hyperplasia. CA Cancer J Clin 1989;39:179-184.
4. Jelovsek FR, Hammond CB, Woodard BH, et al. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol 1980;137:85-91.
5. Ziel HK. Estrogen's role in endometrial cancer. Obstet Gynecol 1982;60:509-512.
6. Levi F, Franeschi S, Negri E, LeVecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993;71:3775-3780.
7. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-66.
8. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
9. Olson TA, Mohanarj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic ovaries. Cancer Res 1994;54:276-280.
10. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
11. Zhang HT, Craft P, Scott PAE, et al. Enhancement of tumor growth and vasular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 1995;87:213-219.
12. Cuttita F, Carney DN, Mulshine J, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer cells. Nature 1985;316:823-826.
13. Frucht H, Gazdar A, Jensen RT. Human colon cancer cell line NCI-H716 expresses functional Bombesin receptors. Proc Am Assoc Cancer Res 1991;32:47-52.
14. Qin Y, Ertl T, Cai RZ, et al. Inhibitor effect of Bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 1994;54:1035-1041.
15. Qin Y, Halmos G, Cai RZ, et al. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of Bombesin to its receptors. J Cancer Res Clin Oncol 1994;200:519-528.
16. Yano T, Pinski J, Groot K, Schally AV. Stimulation by Bombesin and inhibition by Bombesin/gastrin-releasing peptide antagonists RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992;52:4545-4547.
17. Pinski J, Halmos G, Yano T, Szepeshazi K. Effect of somatostatin analog RC-160 and Bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Int J Cancer 1993;55:963-967.
18. Hellmich MR, Ives KL, Udupi V, et al. Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion. J Biol Chem 1999;274:23901-23909.
19. Milanovanovic SR, Radulovic S, Groot K, Shally AV. Inhibition of growth of PC-82 human prostate cancer cell line xenografts in nude mice by bombesin antagonist RC-3095 or combination antagonist [d-Trp6]-lutenizing hormone-releasing hormone and somatostatin analogue RC-160. Prostate 1992;20:269-280.
20. Frucht H, Gazdar AF, Park JA, et al. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992;52:1114-1122.
21. Preston SR, Woodhouse LF, Jones-Blackett S, et al. High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa. Br J Cancer 1995;71:1087-1089.
22. 2+ mobilization but not proliferation of human colon cancer cells. Life Sci 1993;53:1859-1865.
23. Williams BY, Schonbrunn A. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Cancer Res 1994;54:818-824.
24. Van Solinge WW, Odum L, Rehfeld JF. Ovarian cancers express and process progastrin. Cancer Res 1995;53:1823-1828.
25. Sun B, Schally AV, Halmos G. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Reg Peptides 2000;90:77-84.
26. Aprikian AG, Tremblay L, Han K, et al. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase of integrin-associated proteins. Int J Cancer 1997;72:498-504.
27. Ruff M, Schiffmann E, Terranova V, Pert CB. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin Immunol Immunopathol 1985;37:387-396.
28. Rak Jmitsuhashi Y, Bayko L, et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575-4580.
29. Grugel S, Finkenzeller G, Weindel K, et al. Both v-Ha-ras and v-raf stimulate expression of vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 1995;270:25915-25919.
30. McCoy JG, Avery DD. Bombesin: potential integrative peptide for feeding and satiety. Peptides 1990;11:595-607.
31. Brown MR, Carver K, Fisher LA. Bombesin: central nervous system actions to affect the autonomic nervous system. Ann NY Acad Sci 1988;547:174-182.
32. Severi CR, Jensen RT, Ersparmer V, et al. Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. Am J Physiol 1991;206:G683-G690.
33. Ghatei MA, Jung RT, Stevenson JC, et al. Bombesin action on gut hormones and calcium in man. J Clin Endocrinol Metab 1982;54:980-985.
34. Carroll RE, Carroll R, Benya RV. Characterization of gastrin-releasing peptide receptors abberrantly expressed by non-antral gastric adenocarcinomas. Peptides 1999;20:229-237.
35. Markawalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 1999;59:1152-1159.
36. Carney DN, Gazdar AF, Bepler G, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985;45:2913-2923.